Because of the rarity of Budd–Chiari syndrome (BCS), the flow chart of management comes
from expert opinion and is not evidence based. To report an update on the management of …

Abstract In 1845, George Budd published a brief report regarding three patients who
developed an obstruction of the hepatic veins. The condition has never been reported …

The topic of this paper is to report an update on management of Budd-Chiari syndrome
(BCS). Actually, the flow-chart of BCS management comes from experts opinion and is not …

Budd–Chiari syndrome (BCS) occurs as a result of obstruction of hepatic venous outflow at
any level from the small hepatic veins to the junction of the inferior vena cava with the right …

Medical treatment is regarded as the primary course of action in patients with Budd–Chiari
syndrome (BCS). Its efficacy, however, is limited, and most patients require interventional …

Budd–Chiari syndrome is a rare disorder caused by hepatic venous outflow obstruction and
resulting hepatic dysfunction. Despite a lack of prospective randomized trials, much …

Abstract Background Budd-Chiari syndrome (BCS) generally implies thrombosis of the
hepatic veins and/or the intrahepatic or suprahepatic inferior vena cava. Treatment depends …

Budd-Chiari syndrome (BCS) is a rare disease whose management should follow a step by
step strategy. Anticoagulation and medical therapy should be the first line treatment …

Summary Background: Budd‐Chiari syndrome is an uncommon cause of liver failure usually
associated with an underlying hypercoagulable state. Aim: To evaluate current trends in …

Budd‐Chiari syndrome (BCS) is a rare, life‐threatening disease caused by obstruction of
hepatic venous outflow. The aim of the study was to assess long‐term outcome and identify …